title: Leveraging systems biology approaches in clinical pharmacology.
abstract: Computational modeling has been adopted in all aspects of drug research and development, from the early phases of target identification and drug discovery to the late-stage clinical trials. The different questions addressed during each stage of drug R&D has led to the emergence of different modeling methodologies. In the research phase, systems biology couples experimental data with elaborate computational modeling techniques to capture lifecycle and effector cellular functions (e.g. metabolism, signaling, transcription regulation, protein synthesis and interaction) and integrates them in quantitative models. These models are subsequently used in various ways, i.e. to identify new targets, generate testable hypotheses, gain insights on the drug's mode of action (MOA), translate preclinical findings, and assess the potential of clinical drug efficacy and toxicity. In the development phase, pharmacokinetic/pharmacodynamic (PK/PD) modeling is the established way to determine safe and efficacious doses for testing at increasingly larger, and more pertinent to the target indication, cohorts of subjects. First, the relationship between drug input and its concentration in plasma is established. Second, the relationship between this concentration and desired or undesired PD responses is ascertained. Recognizing that the interface of systems biology with PK/PD will facilitate drug development, systems pharmacology came into existence, combining methods from PK/PD modeling and systems engineering explicitly to account for the implicated mechanisms of the target system in the study of drug-target interactions. Herein, a number of popular system biology methodologies are discussed, which could be leveraged within a systems pharmacology framework to address major issues in drug development.
authors: National Technical University of Athens, Athens, Greece; Protatonce Ltd, Athens, Greece.
authors: Ioannis N
authors: IN
authors: Melas
authors: Kosmas
authors: K
authors: Kretsos
authors: Leonidas G
authors: LG
authors: Alexopoulos
mesh_terms: D055808:Drug Discovery; D006801:Humans; D008954:Models, Biological; D010599:Pharmacokinetics; D010601:Pharmacology, Clinical; D049490:Systems Biology
keywords: identification of drug mode of action; modeling of signaling pathways; prediction of clinical drug efficacy; systems biology; systems pharmacology
references: Clin Pharmacol Ther. 2010 Jul;88(1):34-8
references: 20520606
references: Arthritis Rheum. 2007 Jun;56(6):1765-75
references: 17530705
references: Mol Syst Biol. 2009;5:331
references: 19953085
references: Nat Chem Biol. 2010 Apr;6(4):291-9
references: 20190765
references: Annu Rev Pharmacol Toxicol. 2012;52:361-79
references: 22017683
references: Nat Biotechnol. 2008 Mar;26(3):303-4
references: 18327243
references: Nat Biotechnol. 2002 Feb;20(2):155-62
references: 11821861
references: J Comput Biol. 2004;11(4):544-61
references: 15579231
references: J Cell Physiol. 2010 Nov;225(2):364-70
references: 20625992
references: Nat Biotechnol. 2005 May;23(5):554-5
references: 15877071
references: Pharm Res. 2011 Jul;28(7):1480-99
references: 21116694
references: Nature. 2012 Mar 28;483(7391):603-7
references: 22460905
references: Mol Cell Proteomics. 2010 Sep;9(9):1849-65
references: 20460255
references: Curr Opin Chem Biol. 2009 Oct;13(4):398-405
references: 19660979
references: Clin Pharmacol Ther. 2013 May;93(5):379-81
references: 23598453
references: Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):1913-8
references: 18250321
references: Nat Rev Cancer. 2007 Jan;7(1):54-60
references: 17186018
references: Bioinformatics. 2006 Dec 15;22(24):3067-74
references: 17032683
references: Mol Syst Biol. 2009;5:252
references: 19308092
references: PLoS Comput Biol. 2011 Mar;7(3):e1001099
references: 21408212
references: BMC Bioinformatics. 2006 Mar 20;7 Suppl 1:S7
references: 16723010
references: BMC Genomics. 2010 Jul 06;11:419
references: 20604938
references: Trends Pharmacol Sci. 2008 Apr;29(4):186-91
references: 18353445
references: Cancer Res. 2010 Sep 1;70(17):6704-14
references: 20643779
references: Proteomics. 2003 Nov;3(11):2085-90
references: 14595806
references: Clin Pharmacol Ther. 2007 Jul;82(1):21-32
references: 17522597
references: Clin Chem. 2010 Mar;56(3):376-87
references: 20075183
references: Mol Biosyst. 2012 Apr;8(5):1571-84
references: 22446821
references: Annu Rev Pharmacol Toxicol. 2007;47:357-400
references: 17067280
references: Science. 2005 Apr 22;308(5721):523-9
references: 15845847
references: PLoS Comput Biol. 2010 Mar 05;6(3):e1000702
references: 20221256
references: Science. 2008 Jul 11;321(5886):263-6
references: 18621671
references: Pharm Res. 2011 Jul;28(7):1460-4
references: 21560018
references: PLoS Comput Biol. 2009 Dec;5(12):e1000591
references: 19997482
references: Expert Opin Drug Discov. 2010 Dec;5(12):1205-1220
references: 21691435
references: Nat Biotechnol. 2011 Mar;29(3):255-65
references: 21258344
references: Curr Opin Biotechnol. 2010 Aug;21(4):511-6
references: 20554441
references: Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):12841-6
references: 12242336
references: Nucleic Acids Res. 2013 Jan;41(Database issue):D955-61
references: 23180760
references: Biotechnol J. 2012 Mar;7(3):330-42
references: 22125297
references: BMC Syst Biol. 2011 Jul 05;5:107
references: 21729292
references: J Pharmacokinet Pharmacodyn. 2002 Feb;29(1):1-24
references: 12194533
references: J Natl Cancer Inst. 2012 Feb 8;104(3):228-39
references: 22247021
references: Nat Biotechnol. 2007 Sep;25(9):1035-44
references: 17721511
references: PLoS Comput Biol. 2007 Jul;3(7):e130
references: 17616983
references: PLoS Comput Biol. 2009 Apr;5(4):e1000340
references: 19343194
references: PLoS Comput Biol. 2007 Jun;3(6):e109
references: 17559300
references: J Biomed Inform. 2011 Dec;44(6):1102-12
references: 21782035
references: Mol Syst Biol. 2011 Jun 21;7:501
references: 21694718
references: Proc Natl Acad Sci U S A. 2010 Aug 17;107(33):14621-6
references: 20679242
references: Proc Natl Acad Sci U S A. 2012 Jul 10;109(28):11178-83
references: 22711801
references: Cancer Discov. 2012 Mar;2(3):214-26
references: 22585993
references: J Med Chem. 2009 Dec 24;52(24):8038-46
references: 19891439
references: BMC Syst Biol. 2012 Oct 18;6:133
references: 23079107
references: Mol Biosyst. 2010 Jul;6(7):1195-206
references: 20361094
references: BMC Syst Biol. 2007 Jan 08;1:2
references: 17408509
references: Nat Cell Biol. 2006 Nov;8(11):1195-203
references: 17060902
references: J Theor Biol. 1969 Mar;22(3):437-67
references: 5803332
references: Sci Signal. 2012 Apr 17;5(220):re1
references: 22510471
references: Mol Syst Biol. 2007;3:78
references: 17299415
references: Annu Rev Pharmacol Toxicol. 2011;51:45-73
references: 20854171